Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | 0.67% | 345.22 | 1.2% | $624.02m | |
| GILD | Gilead Sciences, Inc. | -3.53% | 72.92 | 0.9% | $510.71m | |
| CELG | Celgene Corporation | 0.24% | 90.37 | 1.2% | $496.41m | |
| AMGN | Amgen Inc. | 0.50% | 197.42 | 1.2% | $485.34m | |
| ILMN | Illumina, Inc. | -0.34% | 325.88 | 3.5% | $373.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.67% | 374.26 | 2.6% | $315.78m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.64% | 176.08 | 1.9% | $209.08m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.09% | 116.00 | 2.0% | $186.59m | |
| A | Agilent Technologies, Inc. | -1.28% | 64.66 | 1.5% | $159.27m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.52% | 130.25 | 16.6% | $142.46m | |
| NKTR | Nektar Therapeutics | 0.13% | 60.03 | 5.6% | $126.29m | |
| BLUE | Bluebird Bio, Inc. | 1.15% | 158.00 | 14.6% | $121.57m | |
| EXAS | Exact Sciences Corporation | 0.33% | 48.84 | 25.3% | $118.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.69% | 101.01 | 4.4% | $118.74m | |
| INCY | Incyte Corporation | 1.40% | 68.80 | 2.5% | $111.73m |
Company Profile
CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.